BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10706072)

  • 1. Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells: implications for adoptive immunotherapy.
    Brouwer RE; Zwinderman KH; Kluin-Nelemans HC; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    Exp Hematol; 2000 Feb; 28(2):161-8. PubMed ID: 10706072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Li L; Schmitt A; Reinhardt P; Greiner J; Ringhoffer M; Vaida B; Bommer M; Vollmer M; Wiesneth M; Döhner H; Schmitt M
    Cancer Immun; 2003 Jul; 3():8. PubMed ID: 12862419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission.
    Whiteway A; Corbett T; Anderson R; Macdonald I; Prentice HG
    Br J Haematol; 2003 Feb; 120(3):442-51. PubMed ID: 12580958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses.
    Brouwer RE; van der Hoorn M; Kluin-Nelemans HC; van Zelderen-Bhola S; Willemze R; Falkenburg JH
    Hum Immunol; 2000 Jun; 61(6):565-74. PubMed ID: 10825585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.
    Costello R; Mallet F; Chambost H; Sainty D; Arnoulet C; Gastaut JA; Olive D
    Leukemia; 1999 Oct; 13(10):1513-8. PubMed ID: 10516751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of leukemic blasts to lymphokine activated killer (LAK)-mediated cytotoxicity is not related to their adhesion properties.
    Palucka AK; Porwit A; Reizenstein P
    Eur J Haematol; 1991 Aug; 47(2):123-7. PubMed ID: 1716215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
    Bruserud O; Ulvestad E
    Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis.
    Brouwer RE; Hoefnagel J; Borger van Der Burg B; Jedema I; Zwinderman KH; Starrenburg IC; Kluin-Nelemans HC; Barge RM; Willemze R; Falkenburg JH
    Br J Haematol; 2001 Nov; 115(2):298-308. PubMed ID: 11703324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens.
    Li L; Reinhardt P; Schmitt A; Barth TF; Greiner J; Ringhoffer M; Döhner H; Wiesneth M; Schmitt M
    Cancer Immunol Immunother; 2005 Jul; 54(7):685-93. PubMed ID: 15627212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosine arabinoside induces costimulatory molecule expression in acute myeloid leukemia cells.
    Vereecque R; Saudemont A; Quesnel B
    Leukemia; 2004 Jul; 18(7):1223-30. PubMed ID: 15152266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage.
    Re F; Arpinati M; Testoni N; Ricci P; Terragna C; Preda P; Ruggeri D; Senese B; Chirumbolo G; Martelli V; Urbini B; Baccarani M; Tura S; Rondelli D
    Exp Hematol; 2002 Feb; 30(2):126-34. PubMed ID: 11823047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomas.
    Chaperot L; Jacob MC; Molens JP; Manches O; Bensa JC; Plumas J
    Leuk Lymphoma; 2000 Jul; 38(3-4):247-63. PubMed ID: 10830732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells.
    Notter M; Willinger T; Erben U; Thiel E
    Blood; 2001 May; 97(10):3138-45. PubMed ID: 11342441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts.
    Aldinucci D; Poletto D; Nanni P; Degan M; Rupolo M; Pinto A; Gattei V
    Exp Hematol; 2002 Nov; 30(11):1283-92. PubMed ID: 12423681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model.
    Ma Q; Wang C; Jones D; Quintanilla KE; Li D; Wang Y; Wieder ED; Clise-Dwyer K; Alatrash G; Mj Y; Munsell MF; Lu S; Qazilbash MH; Molldrem JJ
    Cytotherapy; 2010 Dec; 12(8):1056-62. PubMed ID: 20735170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts.
    Li L; Giannopoulos K; Reinhardt P; Tabarkiewicz J; Schmitt A; Greiner J; Rolinski J; Hus I; Dmoszynska A; Wiesneth M; Schmitt M
    Int J Oncol; 2006 Apr; 28(4):855-61. PubMed ID: 16525634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
    Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
    Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.